H
Hugh D. Riordan
Publications - 46
Citations - 995
Hugh D. Riordan is an academic researcher. The author has contributed to research in topics: Ascorbic acid & Cancer. The author has an hindex of 16, co-authored 46 publications receiving 959 citations.
Papers
More filters
Journal ArticleDOI
Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later
Michael J. Gonzalez,Jorge R. Miranda-Massari,Edna M. Mora,Angelik Guzmán,Neil H. Riordan,Hugh D. Riordan,Joseph J Casciari,James A. Jackson,Angel A. Román-Franco +8 more
TL;DR: The objective of this review is to provide an updated scientific basis for the use of ascorbic acid, especially intravenously as adjuvant treatment in pharmacological nutritional oncology.
Journal ArticleDOI
Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent
TL;DR: Data is presented which demonstrate the ability to sustain plasma levels of AA in humans above levels which are toxic to tumor cells in vitro and suggests the feasibility of using AA as a cytotoxic chemotherapeutic agent.
Journal Article
A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
Hugh D. Riordan,Joseph J Casciari,Michael J. Gonzalez,Neil H. Riordan,Jorge R. Miranda-Massari,Paul Taylor,James A. Jackson +6 more
TL;DR: Intravenous vitamin C therapy for cancer patients given continuous infusions of 150 to 710 mg/kg/day for up to eight weeks suggests that ascorbate infusions did not adversely affect renal function.
Journal ArticleDOI
Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours
Joseph J Casciari,Neil H. Riordan,T L Schmidt,Xiaolong Meng,James A. Jackson,Hugh D. Riordan +5 more
TL;DR: The effect of ascorbate on doxorubicin efficacy was concentration dependent; low doses were protective while high doses increased cell killing, suggesting tumoricidal concentrations may be achievable in vivo.
Journal Article
Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.
Hugh D. Riordan,Neil H. Riordan,James A. Jackson,Joseph J Casciari,Ron Hunninghake,Michael J. Gonzalez,Edna M. Mora,Jorge R. Miranda-Massari,Norberto Rosario,Alfredo Rivera +9 more
TL;DR: A series of seven cases are presented in which intravenous vitamin C has been used as antineoplastic agent in the treatment of different types of cancers, with no toxic reactions observed at high doses of intravenous Vitamin C.